Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A E Williams

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|July 12, 2013
Retinal changes precede visual dysfunction in the complement factor H knockout mouseJennifer A E Williams, John Greenwood, Stephen E Moss
Plos One|August 27, 2016
Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse RetinaJennifer A E Williams, Dimitris Stampoulis, Chloe E Gunter, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 5, 2015
Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosisHui Shi, Jennifer A E Williams, Li Guo, et al.
The Journal of Biological Chemistry|March 7, 2007
The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascadeGemma L J Fuller, Jennifer A E Williams, Michael G Tomlinson, et al.
Pilot and Feasibility Studies|June 25, 2021
Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trialIoana R Marian, Megan Goff, Jennifer A E Williams, et al.
The Lancet. Rheumatology|November 7, 2022
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility studyJennifer A E Williams, Mae Chester-Jones, Catherine Minns Lowe, et al.
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|July 12, 2013
Retinal changes precede visual dysfunction in the complement factor H knockout mouseJennifer A E Williams, John Greenwood, Stephen E Moss
Plos One|August 27, 2016
Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse RetinaJennifer A E Williams, Dimitris Stampoulis, Chloe E Gunter, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 5, 2015
Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosisHui Shi, Jennifer A E Williams, Li Guo, et al.
The Journal of Biological Chemistry|March 7, 2007
The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascadeGemma L J Fuller, Jennifer A E Williams, Michael G Tomlinson, et al.
Pilot and Feasibility Studies|June 25, 2021
Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trialIoana R Marian, Megan Goff, Jennifer A E Williams, et al.
The Lancet. Rheumatology|November 7, 2022
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility studyJennifer A E Williams, Mae Chester-Jones, Catherine Minns Lowe, et al.
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
Pageof 1